Cabaletta Bio Stock Target Price and Analyst Consensus
CABA Stock | USD 13.32 0.02 0.15% |
The current analyst and expert consensus on Cabaletta Bio is Strong Buy, with 9 strong buy opinions. The current projected Cabaletta Bio target price consensus is 25.29 with 11 analyst opinions. The most common way Cabaletta Bio analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Cabaletta Bio executives and customers to further validate their buy or sell advice. Cabaletta Bio buy-or-sell recommendation module provides average expert sentiment on the projected Cabaletta Bio target price to derive its highest and lowest estimates based on its projected price volatility. Check out Macroaxis Advice on Cabaletta Bio to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade Cabaletta Stock refer to our How to Trade Cabaletta Stock guide.
Lowest Forecast 23.01 | Highest Forecast 28.07 | Target Price 25.29 |
Cabaletta |
It's important to approach Cabaletta Bio's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Cabaletta Bio price targets
Cabaletta Bio's stock target price is an estimate of its future price, usually made by analysts. Using Cabaletta Bio's target price to determine if it is a suitable investment can be done through the following steps:- Look at Cabaletta Bio's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Cabaletta Bio's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Cabaletta Bio Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Cabaletta Bio is a key component of Cabaletta Bio valuation and have some predictive power on the future returns of a Cabaletta Bio.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cabaletta Bio's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.Driverless Cars Invested a lot of shares | ||
Manufacturing Invested over 40 shares | ||
Investor Favorites Invested over 50 shares | ||
ESG Investing Invested few shares | ||
Hedge Favorites Invested over 70 shares | ||
Power Assets Invested over 200 shares | ||
Momentum Invested over 200 shares | ||
Dividend Beast Invested over 70 shares | ||
Check out Macroaxis Advice on Cabaletta Bio to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade Cabaletta Stock refer to our How to Trade Cabaletta Stock guide.Note that the Cabaletta Bio information on this page should be used as a complementary analysis to other Cabaletta Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Complementary Tools for Cabaletta Stock analysis
When running Cabaletta Bio's price analysis, check to measure Cabaletta Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cabaletta Bio is operating at the current time. Most of Cabaletta Bio's value examination focuses on studying past and present price action to predict the probability of Cabaletta Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cabaletta Bio's price. Additionally, you may evaluate how the addition of Cabaletta Bio to your portfolios can decrease your overall portfolio volatility.
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Transaction History View history of all your transactions and understand their impact on performance | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
The data published in Cabaletta Bio's official financial statements usually reflect Cabaletta Bio's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Cabaletta Bio. For example, before you start analyzing numbers published by Cabaletta accountants, it's critical to develop an understanding of what Cabaletta Bio's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Cabaletta Bio's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Cabaletta Bio's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Cabaletta Bio's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Cabaletta Bio. Please utilize our Beneish M Score to check the likelihood of Cabaletta Bio's management manipulating its earnings.